Pramanicin induces apoptosis in Jurkat leukemia cells: A role for JNK, p38 and caspase activation

Apoptosis

Volumn 10, Issue 3, 2005, Pages 597-609

  Kutuk, O ^a   Pedrech, A ^b   Harrison, P ^b   Basaga, H ^a  

^a SABANCI UNIVERSITY   (Turkey)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Caspases; Jurkat; Mitogen activated protein kinases; Pramanicin

Indexed keywords

ANTIFUNGAL AGENT; CASPASE; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PRAMANICIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME RELEASE; FLUOROMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANTIFUNGAL AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CASPASES; CYTOCHROMES C; ENZYME ACTIVATION; EPOXY COMPOUNDS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; KINETICS; LACTAMS; MITOCHONDRIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 21244499786     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10495-005-1894-z     Document Type: Article

References (33)

1. Schwartz RE, Helms RG, Bolessa EA, et al. Pramanicin, a novel antimicrobial agent from a fungal fermentation. Tetrahedron 1994; 50: 1675-1686.
2. 2+ and causes cell death in vascular endothelial cells. Vascul Pharm 2003; 40: 35-42.
3. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69: 217-245.
4. Daniel PT. Dissecting the pathways to death. Leukemia 2000; 14: 2035-2044.
5. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256: 42-49.
6. Joza N, Kroemer G, Penninger JM. Genetic analysis of the mammalian cell death machinery. Trends Genet 2002; 18: 142-149.
7. Kuida K, Boucher DM. Functions of MAP kinases: Insights from gene-targeting studies. J Biochem (Tokyo) 2004; 135: 653-656.
8. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004; 23: 2838-2849.
9. Davis RJ. Signal Transduction to the nucleus by MAP Kinases in signaling networks and cell cycle control. In: Gutkind JS, ed. The Molecular Basis of Cancer and Other Diseases. Totowa, NJ: Humana Press 2000: 153-164.
10. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
11. Franklin RA, McCubrey JA. Kinases: Positive and negative regulators of apoptosis. Leukemia 2000; 14: 2019-2034.
12. Liu ZG, Hsu H, Goeddel DV, et al. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 1996; 87: 565-576.
13. Lenczowski JM, Dominguez L, Eder AM, et al. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 1997; 17: 170-181.
14. Rodrigues GA, Park M, Schlessinger J. Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J 1997; 16: 2634-2645.
15. Stofega MR, Yu CL, Wu J, et al. Activation of extracellular signal-regulated kinase (ERK) by mitogenic stimuli is repressed in v-Src-transformed cells. Cell Growth Differ 1997; 8: 113-119.
16. Ory S, Morrison DK. Signal transduction: Implications for Ras-dependent ERK signaling. Curr Biol 2004; 14: R277-R278.
17. Duspara P, Jenkins SI, Hughes DW, et al. The biosynthesis of pramanicin: Intact incorporation of serine and absolute configuration of the antibiotic. Chem Comm 1998; 23: 2643-2644.
18. Frelin C, Imbert V, Griessinger E, et al. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cells. Oncogene 2003; 22: 8187-8194.
19. Kutuk O, Basaga H. Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine 2004; 25: 229-237.
20. Pique M, Barragan M, Dalmau M, et al. Aspirin induces apoptosis through mitochondrial cytochromec release. FEBS Lett 2000; 480: 193-196.
21. Wang X, Martindale JL, Liu Y, et al. The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 1998; 333: 291-300.
22. Viktorsson K, Ekedahl J, Lindebro MC, et al. Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line. Exp Cell Res 2003; 289: 256-264.
23. Schweyer S, Soruri A, Meschter O, et al. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br J Cancer 2004; 91: 589-598.
24. Giri DK, Pantazis P, Aggarwal BB. Cellular resistance to vincristine suppresses NF-kappa B activation and apoptosis but enhances c-Jun-NH2-terminal protein kinase activation by tumor necrosis. Apoptosis 1999; 4: 291-301.
25. Harrison PHM, Duspara PA, Jenkins SI, et al. The biosynthesis of pramanicin in Stagonospora sp ATCC 74235: A modified acyltetramic acid. J Chem Soc Perkin Trans I 2000; 24: 4390-4402.
26. Choi HJ, Lee SY, Cho Y, et al. JNK activation by tetrahydrobiopterin: Implication for Parkinson's disease. J Neurosci Res 2004; 75: 715-721.
27. Hunot S, Vila M, Teismann P, et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 2004; 101: 665-670.
28. Blaker H, Helmchen B, Bonisch A, et al. Mutational activation of the RAS-RAF-MAPK and the wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol 2004; 39: 748-753.
29. Tournier C, Hess P, Yang DD, et al. Requirement of JNK for stress-induced activation of the cytochrome c -mediated death pathway. Science 2000; 288: 870-874.
30. Lin A, Dibling B. The true face of JNK activation in apoptosis. Aging Cell 2002; 1: 112-116.
31. Mukundan L, Milhorn DM, Matta B, et al. CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway. Cell Signal 2004; 16: 375-384.
32. Wilson DJ, Alessandrini A, Budd RC. MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis. Cell Immunol 1999; 194: 67-77.
33. van den Brink MR, Kapeller R, Pratt JC, et al. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem 1999; 274: 11178-11185.